Previous 10 | Next 10 |
DUBLIN , Feb. 24, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops , will present at the Cowen and Company 40 th Annual Health Care Conference on Monday, March 2, 2020 at 3:30 p.m. ET ( 8:30 p.m. GMT ) from Boston ....
DUBLIN , Feb. 19, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the SVB Leerink Global Healthcare Conference on Wednesday, Feb. 26, 2020 at 9:00 a.m. ET ( 2:00 p.m. GMT ) from New York . The presentation ma...
Quick Take Passage Bio ( PASG ) intends to raise $126 million in an IPO of its common stock, per an amended registration statement . The company is advancing a pipeline of genetic treatment candidates for monogenic (single gene pair) central nervous system [CNS] conditions. PASG has yet...
Curaleaf (CURA CN) initiated with Neutral rating and C$11.40 (41% upside) price target at Cantor Fitzgerald. U.S. ticker: ( OTCPK:CURLF ). More news on: Curaleaf Holdings, Inc., Pfenex Inc., Trulieve Cannabis Corp., Healthcare stocks news, Stocks on the move, , Read more ...
Image source: The Motley Fool. Alkermes PLC (NASDAQ: ALKS) Q4 2019 Earnings Call Feb 13, 2020 , 8:00 a.m. ET Operator Continue reading
Alkermes plc (ALKS) Q4 2019 Earnings Conference Call February 13, 2020 08:00 AM ET Company Participants Sandra Coombs - Vice President, Investor Relations Richard Pops - Chairman and Chief Executive Officer James Frates - Senior Vice President and Chief Financial Officer Iain B...
Alkermes ( ALKS ) Q4 results : Revenues: $412.7M (+30.7%); Vivitrol: $92.8M (-89.4%); Aristrada: $56.8M (-91.4%); Manufacturing and royalty revenues: $107.3M (-35.9%); License revenues: $144.8M; R&D revenue: $11.1M (-22.8%). More news on: Alkermes plc, Healthcare stocks news, Earnings...
The following slide deck was published by Alkermes plc in conjunction with their 2019 Q4 earnings Read more ...
DUBLIN , Feb. 13, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported financial results for the quarter and year ended Dec. 31, 2019 and provided financial expectations for 2020. "2019 was an important year for Alkermes as we took active steps to shape the future o...
Alkermes (NASDAQ: ALKS ) is scheduled to announce Q4 earnings results on Thursday, February 13th, before market open. The consensus EPS Estimate is $0.66 (+94.1% Y/Y) and the consensus Revenue Estimate is $404.5M (+28.1% Y/Y). Over the last 2 years, ALKS has beaten EPS estimates 75% ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-22 10:45:03 ET Enbridge Inc (ENB) ENB is trading UP for the last 5 days, and it at trading at $36.59 with volume of 731,965 and a one day change of $0.05 (0.14%). Enbridge Inc has a 52-week low of 31.03 and a 52-week high of $38.36. The business's 50-day moving average price...
Alkermes to Report Second Quarter Financial Results on July 24, 2024 PR Newswire DUBLIN , July 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET ( 1:00 p.m. BST ) on Wednesday, ...
2024-06-29 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...